Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aducanumab
aducanumab
Go or no go? Big decisions loom for Bristol and Sanofi
EP Vantage
Fri, 10/30/20 - 10:12 am
FDA
Bristol-Myers Squibb
aducanumab
Sanofi
sutimlimab
Y-mAbs
Danyelza
Aducanumab’s day of reckoning approaches
EP Vantage
Fri, 10/23/20 - 10:29 am
Biogen
earnings
aducanumab
FDA
Alzheimer's disease
Biogen is running out of safety nets
BioPharma Dive
Thu, 10/22/20 - 10:53 am
Biogen
Vumerity
Tecfidera
Spinraza
aducanumab
Biogen Alzheimer's Drug Headed For Unfavorable Vote, Says An Analyst's Mock Panel
Investors Business Daily
Mon, 10/19/20 - 10:53 am
Biogen
aducanumab
Alzheimer's disease
FDA
analysts
advisory panels
mock advisory panels
Biogen's all-important Alzheimer's drug enters the review gauntlet
BioPharma Dive
Tue, 09/29/20 - 11:38 pm
Biogen
FDA
aducanumab
Alzheimer's disease
Biogen nabs speedy FDA review for controversial Alzheimer’s drug
Fierce Biotech
Fri, 08/7/20 - 11:00 am
Biogen
aducanumab
Eisai
FDA
Alzheimer's disease
priority review
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
BioSpace
Thu, 07/9/20 - 10:27 pm
Alzheimer's disease
drug development
diagnostics
aducanumab
Biogen
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing
Xconomy
Thu, 07/9/20 - 12:12 am
Biogen
FDA
aducanumab
Alzheimer's disease
Third-quarter events to watch for large drug makers
EP Vantage
Mon, 06/22/20 - 10:35 am
Biogen
aducanumab
Sanofi
THOR-707
Bristol-Myers Squibb
pegbelfermin
Eli Lilly
FDA
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout
Fierce Pharma
Thu, 05/7/20 - 10:17 pm
Biogen
Alzheimer's disease
aducanumab
FDA
drug manufacturing
Has Biogen Found the Answer to Treating Alzheimer's?
Motley Fool
Fri, 05/1/20 - 11:07 am
Biogen
FDA
Alzheimer's disease
aducanumab
Biogen shares fall as company pushes back Alzheimer’s drug filing
MedCity News
Wed, 04/22/20 - 11:11 am
Biogen
earnings
Alzheimer's disease
aducanumab
FDA
Biogen Alzheimer's filing likely hit by pandemic, as drugs against the disease set for delay
Fierce Biotech
Tue, 04/14/20 - 10:06 am
Biogen
Alzheimer's disease
aducanumab
FDA
pandemic
COVID-19
Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment
BioSpace
Sat, 04/11/20 - 10:59 pm
Biogen
patents
Alzheimer's disease
aducanumab
Creative Biolabs
Biogen sues over 'brazenly' copied aducanumab drug
Fierce Biotech
Thu, 03/19/20 - 11:10 am
Biogen
Creative Biolabs
Alzheimer's disease
aducanumab
Biogen Could Score a Major Win if Alzheimer's Drug Gets the Green Light
Motley Fool
Fri, 02/28/20 - 11:49 pm
Biogen
Alzheimer's disease
aducanumab
Biogen Profits Up in 2019 Despite Aducanumab Drama
BioSpace
Thu, 01/30/20 - 09:24 pm
Biogen
earnings
aducanumab
2 Reasons to be Optimistic About Biogen’s Alzheimer’s Drug
Motley Fool
Tue, 01/21/20 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Analysts tip Biogen to file for aducanumab approval within weeks
Fierce Biotech
Thu, 01/16/20 - 10:10 am
Biogen
Alzheimer's disease
aducanumab
FDA
JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing
Fierce Pharma
Tue, 01/14/20 - 10:49 am
Biogen
Alzheimer's disease
drug pricing
aducanumab
JPMHC 2020
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »